Platelet-derived growth factor (PDGF) plays a role as a potent mitogen and chemotactic molecule for various cells such as fibroblasts, vascular smooth muscle cells, and glial cells.1>2) PDGF and its receptor are believed to participate in various physiological events such as development or healing. There are two subtypes ofPDGF; PDGFA and PDGF B. These molecules form three types of homoor heterodimers (PDGF AA, PDGF BB, and PDGF AB), and can interact with the extracellular domains of their specific receptors, designated a-receptor and /S-receptor, with different affinities.3~5) Both the receptors have tyrosine kinase domains in their intracellular regions, and the dimerization of the receptor following autophosphorylation induced by the ligands is thought to be essential for signal transduction in cells. 6'7) Evidence indicates that PDGFmay be involved in the pathogenesis of various proliferative, diseases including tumorigenesis,8) fibrosis, atherosclerosis, and restpp. 235 -244 enosis.9'10) Recent findings showed that anti-PDGF antibody can revert the transformed phenotype or can prevent vascular intimal hyperplasia. 1 1} Therefore, drugs which block the activation of the PDGFreceptor would have potential as antitumor substances or for treatment of atherosclerosis.
In the course of our screening work to obtain inhibitors of the binding of the PDGFsto their receptors, we found that azaphilones, designated RP-1551s, produced by a fungus, Penicillium sp. SPC-21609 have inhibitory activity. Here we report the fermentation, purification, and biochemical properties of RP-1551s.
Materials and Methods

Materials
The extracellular domain of the recombinant human PDGF a-receptor, the extracellular domain of re-combinant human PDGF jS-receptor, recombinant human PDGF AA with the KT3 epitope (TPPPEPET), and anti-KT3 antibody were prepared as described by Fretto, et USA). ( +)-Sclerotiorin13) was purified by conventional methods from an in-house fermentation of a fungus, Penicillium sp. RP-1719, which was recently isolated from soil. The structure of sclerotiorin was established by the analyses of its XHand 13C NMR,UV, and mass spectra. All other chemicals were of analytical grade.
Microorganism
The producing microorganism, Penicillium sp. SPC-21609 (FERM BP-4768), was isolated from a soil sample collected in Kanagawaprefecture, Japan.
Culture and MediumCondition
Mycelia grown on an agar slant were inoculated into 10ml of seed medium composed of mashed potato (Yukijirushi) 3%, D-glucose 10%, and yeast extract 0.5% (pH 6.5 before sterilization) in a 50-ml culture tube. The inoculated tube was incubated for 7 days at 25°C on a reciprocating shaker. A 5-ml aliquot of the seed culture was transferred into a 300-ml Erlenmeyer flask containing 50ml seed medium and the inoculated flask was incubated for 5 days at 25°C on a rotary shaker. The entire culture broth of the second culture was transferred into a 2-liter Erlenmeyer flask containing 500ml fermentation mediumconsisting of sucrose 3%, soluble starch 2%, dried yeast (Ebios) 0.5%, malt extract 1%, corn steep liquor 0.5%, V8 vegetable juice (Campbell) 20% (v/v), CaCO3 0.5% (pH 6.5 before sterilization) for 7 days at 25°C. For the purification of RP-1551-M1 and RP-1551-M2, the fermentation was carried out in a large scale with 2,000-liter tank fermenter. Mycelia, grown on an agar slant, were inoculated into 30 ml of seed medium described above in a 250-ml Erlenmeyer flask, and the inoculated tube was incubated for 3 days at 28°C. A 6-ml aliquot of the seed culture was transferred into a 2-liter Erlenmeyer flask containing 300 ml seed medium and the inoculated flask was incubated for 3 days at 28°C on a rotary shaker. Two liters of the second seed culture were transferred into a 200-liter tank fermenter containing 100 liters of the seed medium. The tank was operated for 3 days at 28°C with agitation at 200 rpm MAR. 1999 and aeration of 60 liters per minute. The entire culture broth of the tank fermenter was transferred into a 2,000-liter tank fermenter containing 1,000 liters of the fermentation mediumcomposed of sucrose 3%, soluble starch 2%, dried yeast (Ebios) 0.5%, malt extract 1%, corn steep liquor 0.5%, V8 vegetable juice (Campbell) 5% (v/v), CaCO3 1.5% (pH 6.5 before sterilization).
The fermentation was conducted for 6 days at 25°C with agitation at 120rpm and aeration of 400 liters per minute.
Determination of RP-1551-1
To detect the RP-1551-1, HPLC analysis was adopted.
The conditions of HPLC analysis are described as follows. The culture broth was centrifuged to obtain mycelia. The mycelia were extracted with the same amountof methanol. Anappropriate amountof the methanol extract was injected into HPLCcolumn (YMC 6mmi.d. x 150mm) developed at 40°C with 85%methanol at flow rate of 1ml/minute with monitoring of absorbance at 254 nm.
Ligand Binding Assays
The PDGF binding assays were performed by a solid-phase method using a specific antibody for the PDGFaccording to the method of Fretto, et al.12) For detection of PDGFAAbinding to the a-receptor, the extracellular domain of the PDGF a-receptor protein was immobilized on a 96-well plate, and incubated with 13ng/ml PDGFAA (containing the KT3 epitope) and a test sample dissolved in methanol or dimethylsulfoxide for 2 hours at roomtemperature in incubation buffer composed of 25mMHEPES (pH 7.8), 100mMNaCl, 0.01% Tween 20, and 0.3% gelatin. After incubation, each well was washed with the incubation buffer. The amount of PDGFbound to the receptors were detected with anti-KT3 antibody. The wells were incubated with 5 //g/ml of the anti-KT3 antibody in the incubation buffer for an hour at 37°C, and the wells were washed again with the incubation buffer. These wells were incubated with secondary antibody (peroxidase -conjugated antibody, 1 : 10,000 diluted with the incubation buffer) for an hour at 37°C. After washing the plate, the peroxidase substrates, 2,2'-azinobis[3-ethylbenzothiazoline-6-sulfo-
nic acid]-diammonium salt (ARTS) and H2O2, were added. The product of the enzymereaction was detected by monitoring the absorbance at 650 nm. The assay for PDGFBB binding were carried out in the same way as those of PDGFAAbinding. In brief, the incubation buffer containing 5ng/ml of PDGFBB and a test sample was incubated with the extracellular domain of the PDGF/J-receptor protein immobilized on a plate for 2 hours at roomtemperature. After washing the plate, the plate was sequentially incubated with 2.5jUg/ml of anti-PDGF BB and secondary antibody (peroxidase-conjugated antibody, 1 : 10,000 diluted with the incubation buffer) for an hour at 37°C. The reaction ofperoxidase was performed as described above.
Results
Production of RP-1551s by Fermentation The time course of RP-1551-1 production in 2-liter flask is shown in Figure 1 . The production ofRP-1551-1 in the culture broth was initiated on day 3 and the amount of RP-1551-1 increased up to day 7.
Isolation and Purification
The isolation procedures for RP-1551s are outlined in Figure 2 and Figure 3 . The RP-1551s (other than RP-1551-Ml and -M2) were purified from the fermentation broth cultured in 2-liter flasks. The fermentation broth was filtered to obtain mycelia. The mycelial cake was extracted with methanol. The extract was diluted with an equal volume of water, and applied to a Diaion HP-20 column (3 liter). The column was washed with 50% methanol, and the absorbed material was eluted with methanol-acetone (7 : 3). Fractions containing RP-1551s
were pooled and concentrated in vacuo.
The crude material was applied to a silica gel column (Merck Art. 7734, 1 liter) prepacked with chloroform.
The column was sequentially eluted with 3 liters of chloroform, 3 liters of methylethylketone -chloroform (1 : 9), and 9 liters of methylethylketone-chloroform A small amount of culture broth sampled every day was centrifuged to obtain mycelia. The productivity of RP-1551-1 was determined as described in Materials and Methods.
The productivity of RP-1551-1 in the mycelia (à"),_packed cell volume (%) (O), and pH (A) are indicated.
collected.
Fraction c was concentrated in vacuo to dryness, to yield 787mg ofRP-1551-1 as a yellowpowder. further purified using HPLCby means described in the experimental procedures, and a yellow powder of RP-1551-3 (22mg) was obtained.
RP~1551-7 was purified by silica gel column chromatography and HPLCfrom the Fraction 2 as was done for the other RP-1551 compounds (Fig.  3) . Consequently, RP-1551-7 (57mg) was obtained as a yellow powder. RP-1551-Ml and RP-1551-M2 were isolated from the 1,000-liter culture broth. The purification procedures of these compounds are described in Figure 4 . The culture broth was filtered, and the resulting mycelial cake was extracted with methanol (1,000 liter).
The methanol extract was diluted with an equal amount of water, and passed through a Diaion HP-20 column (50 liter). The column was washed with 50%methanol, eluted wjth (47 mg) (20 mg) Preparative HPLC 85% MeOH RP-1551-6 (6 mg) methanol-acetone (7:3), and the eluate was concentrated in vacuo to yield a brown oily material.
One-fifth of the material was loaded on a silica gel column 
Physico-chemical Properties of RP-1 55 1s
Physico-chemical properties of RP-1551s are summarized in Table 1 . All RP-1551s were obtained as yellow NT; Not tested.
powder. RP-1551-1 is readily soluble in chloroform, methanol, ethanol, acetone, and virtually insoluble in 72-hexane and water. The structures of RP-1551-1, -2, -3, -4, -5, -6, -7, -Ml, and -M2 were determined as 1 to 9, respectively ( Figure  5 ). RP-1551-7 is identical to the known azaphilone, luteusin A. RP-1551-1 and RP-1551-6 are stereoisomers each other, and these are distinct stereoisomers from the known azaphilones, luteusin C and luteusin D.14'15) The structural elucidation will be described in a separate paper.
Biochemical Properties RP-1551-1 inhibited the binding of PDGF AA to the extracellular domain of the PDGF a-receptor in a dose-dependent manner ( Figure 6 ). An IC50 value was calculated to be 1.7jum. RP-1551-1 did not affect the binding of PDGF BB to the PDGF jg-receptor at concentrations up to 50fiM. The inhibitory potency of the RP-1551s are summarized in sclerotiorin, a well-characterized azaphilone produced by In order to further characterize the inhibitory property of RP-1551-1 on the PDGF a-receptor, the following experiments were carried out. In the binding experi- PDGFa-receptor treated with RP-1551-1 or sclerotiorin in this manner. The inhibitory potency was almost equal to that observed without preincubation with the compound and the receptor (Figure 7 ).
The displacement curve by RP-1551-1 was shifted only slightly to the right when RP-1551-1 was incubated with 1 mg/ml bovine serum albumin (BSA) prior to the binding assay, whereas the inhibition by the sclerotiorin was dramatically restored by preincubation with BSA ( Figure  8 ).
The antimicrobial activity of RP-1551-1 is described as follows. RP-1551-1 has weak activity against Bacillus subtilis, Enterococcus faecium, and Staphylococcus aureus. The experiments were carried out in triplicate.
Discussion
In this paper, we report that azaphilones, the RP1551s, were isolated from Penicillium sp. as inhibitors of the PDGF AA binding to the PDGF a-receptor extracellular domain. While RP-1551-7 is identical to a known azaphilone luteusin A, which has been reported as an inhibitor of monoamine oxdase,14'16) the other RP-1551s are novel compounds.
Recently, novel azaphilones isochromophilones have been isolated from the culture broth of Penicillium sp. ranging from 0.1 to 2 /iM, whereas these compounds had no effect on the binding of PDGFBB to the /^-receptor at the sameconcentration ranges. These results suggest that the RP-1551s may be selective blockers of the PDGF a-receptor extracellular domain. We also found the inhibitory effect of sclerotiorin, one of azaphilone compounds which has been demonstrated to possess high reactivity with amino groups,22) on
PDGFbinding to their receptor's extracellular domains. Moreover, sclerotiorin incubated with BSA showed less potent inhibition than non-treated sclerotiorin, suggesting that BSAadded to the reaction mixture may chemically react with the sclerotiorin and neutralize the inhibitory effect of the sclerotiorin. Therefore, it is to the /?-receptor but did affect PDGFAAbinding to the a-receptor, while sclerotiorin inhibited both PDGF AAand PDGFBBbinding. Unlike sclerotiorin, the effect of RP-1551-1 on PDGFAA binding was shifted slightly to the right in the presence ofBSA. These results suggest that RP-1551-1 appears to. react more preferentially with the PDGFa-receptor extracellular domain than with BSA. Therefore, it is likely that this effect is due to the reactivity of RP-1551-1 on protein molecules, and the selectivity of RP-1551-1 to the PDGF a-receptor extracellular domain may be due to the differential reactivity of RP-1551-1 to proteins.
